RVP vs. AKLI, CODX, GBS, ICU, MDAI, NMTC, MODD, FEMY, CTCX, and IINN
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Akili (AKLI), Co-Diagnostics (CODX), GBS (GBS), SeaStar Medical (ICU), Spectral AI (MDAI), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), Femasys (FEMY), Carmell (CTCX), and Inspira Technologies Oxy B.H.N. (IINN). These companies are all part of the "surgical & medical instruments" industry.
Akili (NASDAQ:AKLI) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.
Akili received 6 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 66.67% of users gave Akili an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote.
Akili presently has a consensus price target of $4.00, suggesting a potential upside of 830.23%. Given Retractable Technologies' higher probable upside, equities research analysts clearly believe Akili is more favorable than Retractable Technologies.
Retractable Technologies has a net margin of -16.08% compared to Retractable Technologies' net margin of -3,545.47%. Akili's return on equity of -6.86% beat Retractable Technologies' return on equity.
Akili has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.11, meaning that its stock price is 111% more volatile than the S&P 500.
In the previous week, Akili had 6 more articles in the media than Retractable Technologies. MarketBeat recorded 9 mentions for Akili and 3 mentions for Retractable Technologies. Akili's average media sentiment score of 0.75 beat Retractable Technologies' score of 0.61 indicating that Retractable Technologies is being referred to more favorably in the news media.
53.1% of Akili shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 10.1% of Akili shares are held by company insiders. Comparatively, 54.6% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Retractable Technologies has higher revenue and earnings than Akili. Retractable Technologies is trading at a lower price-to-earnings ratio than Akili, indicating that it is currently the more affordable of the two stocks.
Summary
Retractable Technologies beats Akili on 9 of the 17 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
